Nasdaq IPOs

Caribou Biosciences, a Phase 1 biotech developing gene edited cell therapies for multiple cancers, raised $304 million by offering 19 million shares at $16, the high end of the range of $14 to $16. The company offered 2 million more shares than anticipated. It originally planned

U.S. Century Bank, a community bank in the Miami-Dade MSA, raised $40 million by offering 4 million shares at $10, the low end of the range of $10 to $12.50. U.S. Century has 11 banking centers and a digital banking platform, offering a range of commercial products and services f

Xponential Fitness, a roll-up of franchised boutique fitness brands with over 1,750 studios in North America, raised $120 million by offering 10 million shares at $12, below the range of $14 to $16. The company offered 3.3 million fewer shares than anticipated. Xponential Fitness

Outbrain, which provides an online content marketing platform, raised $160 million by offering 8 million shares at $20, below the range of $24 to $26. Outbrain states that it pioneered the online content recommendation category. Today, its platform enables over 7,000 online prope

Gambling.com Group, which provides digital marketing services to the online gambling industry, raised $42 million by offering 5.3 million shares at $8, the low end of the downwardly revised range of $8 to $9. The company originally planned to offer 7.5 million shares at $11 to $1

Orange County Bancorp, a New York bank with 14 full-service branches across the Lower Hudson Valley, filed an amendment on Thursday with the SEC disclosing plans to raise up to $30 million. The company is currently listed on the OTCQX (OCBI). It originally filed on July 9, 2021,

Icosavax, a Phase 1 biotech developing vaccines for respiratory diseases, announced terms for its IPO on Thursday.The Seattle, WA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Icosava

Rallybio, a Phase 1/2 biotech developing antibody therapies for rare diseases, announced terms for its IPO on Thursday.The New Haven, CT-based company plans to raise $81 million by offering 5.8 million shares at a price range of $13 to $15. At the midpoint of the proposed range,

Juniper II, the second blank check company led by past and present Honeywell execs targeting North American industrials, lowered the proposed deal size for its upcoming IPO on Thursday.The Palo Alto, CA-based company now plans to raise $225 million by offering 22.5 million units

Jade Mountain Acquisition, a blank check company targeting the healthcare and technology sectors, filed on Thursday with the SEC to raise up to $100 million.The Taipei City, Taiwan-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists o

Argus Capital, a blank check company led by former ViacomCBS/CBS executives targeting media, entertainment, and sports, filed on Thursday with the SEC to raise up to $300 million.The New York, NY-based company plans to raise $300 million by offering 30 million units at $10. Each

IN8bio, a Phase 1 oncology biotech developing allogeneic gamma-delta T cell therapies, announced terms for its IPO on Thursday.The New York, NY-based company plans to raise $44 million by offering 4 million shares at a price range of $10 to $12. At the midpoint of the proposed ra

Gambling.com Group, which provides digital marketing services to the online gambling industry, lowered the proposed deal size for its upcoming IPO on Thursday.The St. Helier, Jersey-based company now plans to raise $45 million by offering 5.3 million shares at a price range of $8

Caribou Biosciences, a Phase 1 biotech developing gene edited cell therapies for multiple cancers, raised the proposed deal size for its upcoming IPO on Thursday.The Berkeley, CA-based company now plans to raise $255 million by offering 17 million shares at a price range of $14 t

Zevia PBC, which makes zero calorie soft drinks sweetened with stevia, raised $150 million by offering 10.7 million shares at $14, within the range of $13 to $15. The company offered 3.6 million fewer shares than anticipated. Zevia provides six product lines of zero calorie, zero

Zenvia, which provides a customer experience communications platform in Latin America, raised $150 million by offering 11.5 million shares at $13, the low end of the range of $13 to $15. The company plans to raise an additional $50 million in a concurrent private placement t

Ryan Specialty Group, a wholesale specialty insurance brokerage, raised $1.3 billion by offering 56.9 million shares (63% synthetic secondary) at $23.50, within the range of $22 to $25. Ryan Specialty Group provides specialty insurance solutions for brokers, agents, and carriers.

Instructure Holdings, which provides a learning management platform, raised $250 million by offering 12.5 million shares at $20, within the range of $19 to $21. Instructure states that it provides a next-generation Learning Management System (LMS), assessments for learning, actio

Couchbase, which provides NoSQL database technology for application developers, raised $200 million by offering 8.3 million shares at $24, above the range of $20 to $23. The company originally planned to offer 7.0 million shares at the same range. At pricing, Couchbase commands a

Absci, which provides a platform for the discovery and development of protein therapies, raised $200 million by offering 12.5 million shares at $16, the midpoint of the $15 to $17 range.AbSci states that its Integrated Drug Creation Platform uses synthetic biology technologies an